Aarti Drugs Limited (BOM: 524348)
India
· Delayed Price · Currency is INR 539.85
-4.85 (-0.89%)
At close: Sep 10, 2024
Aarti Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 9, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 48,634 | 39,886 | 31,280 | 39,725 | 64,755 | 11,785 | Upgrade
|
| Market Cap Growth | 7.73% | 27.51% | -21.26% | -38.65% | 449.47% | -21.97% | Upgrade
|
| Enterprise Value | 54,073 | 45,531 | 36,863 | 44,228 | 67,914 | 15,991 | Upgrade
|
| Last Close Price | 529.00 | 433.85 | 337.15 | 427.09 | 690.38 | 125.17 | Upgrade
|
| PE Ratio | 31.11 | 23.27 | 18.77 | 19.29 | 22.95 | 8.25 | Upgrade
|
| PS Ratio | 2.00 | 1.58 | 1.15 | 1.60 | 3.01 | 0.65 | Upgrade
|
| PB Ratio | 3.80 | 3.11 | 2.62 | 3.83 | 7.09 | 1.81 | Upgrade
|
| P/FCF Ratio | - | 30.08 | -99.31 | -48.71 | 97.06 | 5.81 | Upgrade
|
| P/OCF Ratio | - | 11.11 | 23.46 | 56.42 | 41.79 | 4.70 | Upgrade
|
| EV/Sales Ratio | 2.23 | 1.80 | 1.36 | 1.78 | 3.15 | 0.89 | Upgrade
|
| EV/EBITDA Ratio | 17.90 | 14.50 | 12.17 | 13.19 | 15.67 | 6.23 | Upgrade
|
| EV/EBIT Ratio | 21.66 | 17.18 | 14.44 | 15.34 | 17.50 | 7.49 | Upgrade
|
| EV/FCF Ratio | - | 34.34 | -117.04 | -54.23 | 101.79 | 7.89 | Upgrade
|
| Debt / Equity Ratio | 0.44 | 0.44 | 0.51 | 0.52 | 0.38 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 1.87 | 1.79 | 1.99 | 1.60 | 0.80 | 1.49 | Upgrade
|
| Debt / FCF Ratio | - | 4.26 | -19.33 | -6.66 | 5.26 | 1.92 | Upgrade
|
| Asset Turnover | - | 1.04 | 1.17 | 1.25 | 1.29 | 1.19 | Upgrade
|
| Inventory Turnover | - | 3.39 | 3.67 | 3.62 | 3.60 | 4.15 | Upgrade
|
| Quick Ratio | - | 0.92 | 0.94 | 0.84 | 0.97 | 0.82 | Upgrade
|
| Current Ratio | - | 1.66 | 1.57 | 1.48 | 1.78 | 1.45 | Upgrade
|
| Return on Equity (ROE) | - | 13.87% | 14.93% | 21.03% | 35.81% | 23.65% | Upgrade
|
| Return on Assets (ROA) | - | 6.82% | 6.89% | 9.07% | 14.51% | 8.80% | Upgrade
|
| Return on Capital (ROIC) | 8.55% | 9.08% | 9.44% | 12.68% | 21.05% | 12.75% | Upgrade
|
| Earnings Yield | 3.21% | 4.30% | 5.32% | 5.16% | 4.33% | 12.00% | Upgrade
|
| FCF Yield | 3.32% | -1.01% | -2.05% | 1.03% | 17.20% | Upgrade
| |
| Dividend Yield | 0.19% | 0.23% | 0.30% | 0.23% | 0.36% | 0.40% | Upgrade
|
| Payout Ratio | 0.00% | 5.41% | 5.65% | 4.64% | 8.28% | 4.97% | Upgrade
|
| Buyback Yield / Dilution | 0.89% | 0.72% | - | 0.64% | - | 1.20% | Upgrade
|
| Total Shareholder Return | 1.08% | 0.95% | 0.30% | 0.88% | 0.36% | 1.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.